Our Mission
The ACC Nevada Chapter is dedicated to advancing the field of cardiovascular care through innovation, advocacy, and professional development, ensuring that Nevada’s clinicians are equipped to meet the evolving health challenges of our state.
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- ACC CardiaCast: Innovation in Action: AI-Enabled ECG: From Concept to Clinical CareIn this episode with Drs. Francisco Lopez-Jimenez and Paul Friedman, ACC Chief Innovation Officer Dr. Ami Bhatt explores the rapid rise of artificial intelligence (AI) tools in cardiovascular care, highlighting why screening tools such as the electrocardiogram (ECG) are particularly well-suited for innovation.
- ACC Releases Expert Consensus Decision Pathway on TR Evaluation and ManagementThe ACC has released a new Expert Consensus Decision Pathway (ECDP) addressing "10 issues for the clinician in tricuspid regurgitation (TR) evaluation and management."
- Top Posters at ACC Latin America 2025 Explore Myocardial Contraction Fraction, Vericiguat in HFrEF, Long COVIDAs hundreds of participants gathered to share and learn about the latest science from the Latin America region, the top three posters from ACC Latin America 2025 earned a spot to present at ACC.26 in New Orleans, LA.
- Intensive BP Control Provides Net Benefit Between Fewer CV and More Adverse EventsIntensive blood pressure (BP) control compared with standard BP control offers a net benefit between the decrease in cardiovascular events and increase in adverse events, including kidney-related events, according to a meta-analysis published Sept. 6 in The Lancet.
- Partial Heart Transplant Viable Option For Children With Congenital Valve DiseasePartial heart transplant provides a safe and effective valve replacement alterative with the capacity for valve growth in children with congenital heart disease, decreasing the need for reoperation, according to a small retrospective study published Aug. 27 in JAMA.